AU Patent

AU2012241189A1 — Fast Dissolving Solid Dosage Form

Assigned to IX Biopharma Ltd · Expires 2014-04-24 · 12y expired

What this patent protects

There is provided a fast dissolving solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form comprises at least one biologically active material, and at least one matrix forming agent, wherein 5 the dosage form substan…

USPTO Abstract

There is provided a fast dissolving solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form comprises at least one biologically active material, and at least one matrix forming agent, wherein 5 the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit comprising the same are also provided. NO SUITABLE FIGURE

Drugs covered by this patent

Patent Metadata

Patent number
AU2012241189A1
Jurisdiction
AU
Classification
—
Expires
2014-04-24
Drug substance claim
No
Drug product claim
No
Assignee
IX Biopharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.